There's a mass migration happening in science generally but especially human genomic medical-themed researchers!🧬
When the new US govt kicks in this Musk-owned platform is not where I want to be
If you're not already there, come join us 🦋
lcpilling.bsky.social
Wow! Peter Visscher and colleagues have published a provocative paper in Nature speculating that "polygenic gene editing" of embryos might prove effective in reducing disease risk, should the technology advance enough to become safe in the future.
The authors argue that for polygenic diseases like type 2 diabetes or schizophrenia, theoretically, editing only a handful of variants might produce dramatic reduction in the disease prevalence among the edited embryos. And this approach will prove more effective than embryo screening. Of course, the authors have acknowledged that this is speculative and discussed all the challenges and ethical issues associated with embryo gene editing.
Further, Nature has thoughtfully published a well-balanced News and Views titled "Human embryo editing against disease is unsafe and unproven — despite rosy predictions" by experts in this topic (@ShaiCarmi@WiringTheBrain and @HankGreelyLSJU) arguing that though theoretically possible the idea might never work.
Visscher et al. Nature
nature.com/articles/s41586-0…
My blood 🩸 made it all the way to University Hospital, Birmingham where it helped to save or improve someone's life
Love getting these e-mails. Consider signing up to donate blood, if you don't already blood.co.uk@GiveBloodNHS
ALT Map showing the route from Exeter up to the centre in Filton where they ran tests and then processed it into a form that can be given to a patient in need. Once it was ready it was sent to the University Hospital, Birmingham where it will help to save or improve someone's life.
📢December Biomarkers @DEMONNetwork working group will host Dr Alankar Atreya discussing how changes in sleep detected by wrist devices are related to Alzheimer's progression. ⌚️ Wed 11th 10am GMT. All welcome - please message for teams details.
🌟Post-doc available in Exeter with the superb @janemasoli researching cardiovascular ageing using health data science approaches
This is part of a wider NIHR-funded project studying cardiovascular frailty in routine health data
Join us! 🤩
tinyurl.com/yr4e6dkz closes 1 Jan
It is taking a lot of time and e-mails to set up payment to @dnanexus for my group. Still not successful, months after first contacting them!
In speaking to others, this is not uncommon. I *really* want to just pay them and get on with @uk_biobank analyses! Any tips?!
Excited to attend @geronsociety annual meeting this year in #Seattle
Fascinating programme. Looking forward to learning new things, catching up with old friends, and making new collaborations!
Reach out to me if you are also at #GSA2024 and want to connect
Amazing work towards generalisable polygenic scores across ancestries. Though the highest praise goes to whoever came up with DiscoDivas as the name of the method! Bravo 👏
Current polygenic risk scores require binning of ancestry groups but we know ancestry is a continuum. Our study led by @Yunfeng_Ruan introduces DiscoDivas, a new generalizable PRS framework across the ancestry spectrum medrxiv.org/content/10.1101/…@medrxivpreprint @PRSdiversity
Thank you Pradeep for your support and advice for this project🙏😃
We’re thrilled to introduce DiscoDivas, a new method designed to generate Polygenic Risk Scores (PRS) for diverse espcially admixed populations
1/
Exciting times - We are launching our Phyto Ageing study! Are you over 50 and do you have some joint stiffness in your hands? We need volunteers to see if our plant-based dietary supplement improves your symptoms. eu.jotform.com/form/24275458…
This is part of our wider programme of work on hypertension, multimorbidity, pharmacogenetics, and causal inference methods sites.exeter.ac.uk/age/
Please share widely! 🥰
Click below for more information and to apply
exeter.ac.uk/study/funding/a…
Looking forward to hearing from you
Last autumn FinnGen hit its target of sampling close to 10% of the Finnish population with more than 500,000 participants. We are happy to announce that the results based on the full cohort are now publicly available for the whole research community:
finngen.fi/en/results-based-…
Please join the @DEMONNetworkUK
Biomarkers WG on Tuesday, 5th November, at 11am GMT. We are excited to host Dr. Brook Huxford @f_huxford from @preventiveneur1, @QMUL_WIPH, discussing “Peripheral Biomarkers of Neuro-Axonal Damage and Inflammation in Parkinson’s Disease Cohorts.”
Microsoft "Bookings" is game changing! Knew it would be useful for students/tutees - but it makes arranging quick meetings with colleagues so much easier too (no more back and forths "can you do then? what about then?")